The method of embodiment75, wherein the composition comprises between about 0.01% to about 20% by weight of the cholesterol, about 0.01% to about 15% by weight of the cholesterol, about 0.01% to about 10% by weight of the cholesterol, about 0.01% to about 7% by weight of the cholesterol, about 0.01% to about 5% by weight of the cholesterol, about 0.01% to about 3% by weight of the cholesterol, about 0.01% to about 2% by weight of the cholesterol, or about 0.01% to about 1% by weight of the cholesterol
The developed formulations were further freeze-dried to obtain CHX, Propolis, and Liquorice Nanocrystals dried powder [23]
These inhibitors block KEAP1 from binding to NRF2, resulting in the stabilization and activation of NRF2
Informed consent and ethical clearance have been obtained for all individuals included in the dataset
For nanotherapeutic design, the stromal compartment therefore creates two related objectives: improving tissue penetration and modifying stromal signaling in a way that supports therapeutic response
Pleasure, S